Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jianwei Natural Biotechnology is a Chinese plant-extract and health-ingredient company based in Linjiang, Jilin Province. The company specializes in the research, production, and sale of dihydroquercetin (taxifolin), arabinogalactan, and related larch-derived extracts, and it has positioned itself as an early industrial-scale producer of taxifolin in China. Beyond raw ingredients, it has also developed downstream food, skincare, and daily-use products based on these compounds. The business appears focused on nutraceutical, functional food, cosmetic, and health-material commercialization rather than a conventional therapeutic drug pipeline. It is a high-tech enterprise with manufacturing operations in Linjiang and reported sales into North America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jianwei Natural Biotechnology.